Navigation Links
West to Host Investor Day
Date:3/7/2008

LIONVILLE, Pa., March 7 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will conduct a live webcast of its Investor Day event on Thursday, March 13, 2008 from 8:30am to approximately 11:30am EDT. The event will be held at the Grand Hyatt Hotel in New York, New York.

The following members of management will provide an in-depth look at the Company's global operations, business segments, supply chain management and investments in innovation. Speakers will include:
-- Don Morel, Chairman and CEO

-- Steve Ellers, President and COO

-- Mike Schaefers, Director of Marketing, Europe/Asia Pacific

-- John Paproski, Vice President, Innovation

-- Bernie Lahendro, Vice President and General Manager, Daikyo Crystal

Zenith

A live audio webcast and a copy of the presentations will be available through the Investor link of the Company's website, http://www.westpharma.com. A replay of the audio portion will be available for 14 days. To access the live webcast, visit the company's Web site at least 15 minutes prior to the scheduled start time to download any necessary audio or plug-in software.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West Pharmaceutical Services supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at http://www.westpharma.com.

Contacts: Investors and Financial Media:

West Pharmaceutical Services, Inc. FD

Michael A. Anderson Evan Smith / Theresa Kelleher

Vice President and Treasurer (212) 850-5600

(610) 594-3345 wst@fd.com


'/>"/>
SOURCE West Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BD to Present at Investor Healthcare Conferences
2. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
4. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
5. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
6. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
7. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
8. CuraGen to Present at the BIO CEO & Investor Conference
9. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
10. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
11. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight ... for Cancer Research (OICR) are pleased to report that ... A financing, with Johnson & Johnson Innovation – JJDC, ... include venture groups HealthCap, TPG Biotechnology Partners, and Genesys ... ...
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
Breaking Biology Technology:
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... NEW YORK , Jan. 24, 2017 /PRNewswire/ ... market study of the laboratory use of nuclear ... of 363 experienced end-users and profiled current practices, ... three years, as well as growth and opportunities. ... NMR, Instrument suppliers, NMR instruments, needs and innovation ...
Breaking Biology News(10 mins):